Company intelligence / Profile preview

BelleTorus

Cambridge, MA, USAbelle.ai ↗

Ownership: Private
Development stage: Commercial

Overview

BelleTorus has developed a robust suite of artificial intelligence platforms for the identification and severity scoring of over 1,600 skin conditions from smartphone images. Their technology is used globally by healthcare professionals for objective assessment in clinical practice as well as by pharmaceutical companies for research. The company was awarded a $3.5 million ARPA-H contract to expand pediatric telehealth using their platform. Recent patents cover computer-based systems for diagnosing psoriasis and eczema as well as severity scoring of various skin diseases.

Therapeutic areas: Dermatology
Modalities: Artificial intelligence software (for dermatology diagnostics and monitoring)
Industry: Digital Health Medical Devices

Partnerships

Urban Health Plan/UHP (ARPA-H pediatric telehealth project)Collaborations with researchers/pharmaceutical companies worldwide for clinical trials/research support

Beyond the preview

Go deeper on BelleTorus.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BelleTorus.

Explore the full profile